Cancer associated chronic illness - a new cancer story Jane Maher NHS Improvement Lead (cancer) CMO Macmillan cancer Support Chair NCSI Consequences of.

Slides:



Advertisements
Similar presentations
What if the patient wants answers... (and you don’t have them) Dr Geraldine Swift and Dr Sonia Mangwana.
Advertisements

Rapid Admission of Palliative Patients. Hospital Macmillan Specialist Palliative Care Nurse. Lung Cancer Specialist Palliative Care Nurse. September 2008.
Reinventing Cancer Support Ciarán Devane Chief Executive.
Patients’ supportive care needs beyond the end of treatment: A prospective, longitudinal study.
National Cancer Survivorship Initiative
Survivorship Update February 2012
Preventing Cancer with Healthy Life Styles Li-Fen L. Chang, M.D., Ph.D. Radiation Oncology SOMC Cancer Center.
Improving Cancer Outcomes at a national level - The story from England Professor Sir Mike Richards National Cancer Director June
Living with and beyond treatment for cancer – the challenge for secondary care Nigel Acheson Medical Director Peninsula Cancer Network.
Gynaecological Cancers
Survivorship – why bother? Jane Maher NHS Improvement Lead (cancer) Chief Medical Officer, Macmillan cancer Support Chair NCSI Consequences of treatment.
Supporting Cancer Survivors - A New Aftercare System
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Early Diagnosis of Cancer Working with GP Practices in Islington.
NHS Improvement National Conference Cancer Survivorship – Living with and Beyond Cancer “ACHIEVING EQUITABLE and CONTEMPORARY SERVICES for all Cancer SURVIVORS”
A simple method to estimate survival trajectories Dr. Matt Williams ICHNT & IC E-Oncology Feb 2015
Key Messages National Cancer Survivorship Initiative Central Hall, Westminster Monday 21 September 2009.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need Primary Care CQUIN PPG Chairs Meeting – 20 th April, 2015.
Cancer Survivorship Care Why, What, Where Kenneth Miller, M.D. Sinai Hospital Baltimore, MD.
Community Oncology Conference Thursday April 23 rd, 2015.
Greg Rubin Professor of General Practice and Primary Care University of Durham.
BRIGHTEN UP ® A Bright Pink Educational Initiative Copyright 2014 © Bright Pink all rights reserved, including the right of reproduction in whole or in.
Beyond Primary Treatment Professor Jane Maher Joint Chief Medical Officer Macmillan Cancer Support.
National Homecare Conference Anne Willis Hospice Manager : Marie Curie Hospice : Edinburgh.
Beyond Standard Adjuvant Therapy for Colon Cancer: Role of Nonstandard Interventions Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA.
Preventing cancer Diana Sarfati Director, Cancer Control and Screening Research Group.
Prostate Cancer Coalition of North Carolina Prostate Cancer / Breast Cancer Brother / Sister Diseases Your Name PCCNC Women’s Programs Your.
Electronic Cancer Referral Dr Regina Codd GP Community Oncology Team NCCP.
Chemotherapy Audit  Audit of patients who died within three months of their last dose of chemotherapy at Airedale General Hospital  The records of 50.
National Cancer Survivorship Initiative The future requirements for Children and Young People Gill Levitt National Clinical Lead.
1 Communicating the National Cancer Survivorship Initiative Vision Stephen Hindle.
Barb Supanich, RSM, MD, FAAHPM Holy Cross IP Palliative Care Team November 11, 2010.
Renal Services Dr Donal O’Donoghue National Clinical Director for Kidney Care UKRR Annual Audit Meeting QEH Birmingham 30 September 2010 Working for Better.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
1000 Lives Annual Report North of England Cancer Network Annual Conference 20 th September 2013.
Diversity and the Burden of Cancer David C. Momrow, M.P.H. Senior Vice President of Cancer Control American Cancer Society – Eastern Division January 21,
Supporting people with active and advanced disease Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative.
Consequences of cancer & its treatment Jane Maher NHS Improvement Lead (cancer) Chief Medical Officer, Macmillan Cancer Support Chair, NCSI Consequences.
Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.
MHPE Volunteer Resource ILLNESS PREVENTION Cancer and its prevention Tab 21.
Cancer Services Collaborative A Service Improvement Partnership between Cancer Networks, the National Cancer Programme and the NHS Modernisation Agency.
Can Nurses Assist Older CHF Patients With Self-Care? Sallie A. Alvarez NGR 5800 American Heart Association.
Supporting people with active and advanced disease Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
Men’s Health Week June Underground Atlanta Eat Street Food Truck Wednesday Eat Street Food Truck Wednesday.
National Cancer Survivorship Initiative Ciarán Devane Chief Executive, Macmillan Cancer Support.
National Cancer Survivorship Initiative 2010 Update.
Early Treatment of Relapsed Ovarian Cancer Based on CA125 Level Alone Versus Delayed Treatment Based on Conventional Clinical Indicators Results of the.
How clinicians use data to make an impact on clinical outcomes Andrew Brodbelt Consultant Neurosurgeon and Clinical Director of Neurosurgery, The Walton.
Consequences of cancer and its treatment. Improvements in early detection and diagnosis More advanced treatments From acute to long-term condition Increasing.
Health & Wellbeing in Oldham Alan Higgins Director of Public Health Oldham.
CANCER. Terms Tumor - An abnormal mass that has no role in the body. Benign – Non cancerous. Malignant - Cancerous. Metastasis - Cancer has spread from.
“What happens next?” The role of the Lymphoma End of Treatment clinic Karen Stanley Macmillan Lymphoma Clinical Nurse Specialist
1 Overview of presentation 1.Context 2.Objectives 3.Methods 4.What has been achieved 5.What has to be done NCSI-CYP – Risk Stratification Investigation.
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
Cancer By: Summer Diego(:. The four most common cancers!  Lung Cancer  Prostate Cancer  Breast Cancer  Colon Cancer.
2016 Implementing the Recovery Package. 1. Overview of Living with and Beyond Cancer 2.Promote wider understanding of Recovery Package 3.Explore stratification.
Macmillan Next Steps Cancer Rehabilitation
Palliative Care: Emergency Room Interaction
Long Term Effects of Cancer Treatment
Annual General Meeting
The Changing Story of Cancer
A Few Facts About Breast Cancer
The Relationship Between Mental and Physical Health
AN OVERVIEW OF THE BONE METASTASES PROGRAM
Healthy Choices = Healthy Living
Local networking sessions
Cancer associated chronic illness - a new cancer story
Living with and beyond Cancer
Presentation transcript:

Cancer associated chronic illness - a new cancer story Jane Maher NHS Improvement Lead (cancer) CMO Macmillan cancer Support Chair NCSI Consequences of treatment work stream

Cancer in the UK in ,000 new cases of cancer in UK in ,000 cancer deaths in UK in million cancer survivors in UK in % 65+ are cancer survivors increasing by 3.2% each year 1 Based on NCIS data for England in All figures refer to all malignant neoplasms excluding non-melanoma skin cancer (ICD-10 C00-C97 excl. C44).

Current public (& professions’) view of cancer Incurable cancer Cured cancer

. The new “incurable cancer “ story Chronic phase Multiple courses of Chemotherapy Actively managing EOL

. “incurable cancer “ Many people with incurable cancer can live good quality lives Not all will die “soon”, many live with their disease for years Different “patterns of illness (chronic, progressive, dying)

Eg looking at survival curves of a cohort pf patients treated with “palliative” RT ….. Lung 7.5 months (Other 5 months) Breast 22.3 months Prostate 23 months Breast/prostate

. “incurable cancer “ Treatment as early as possible & for as long as possible not always the answer

Overall Survival Ovarian cancer (OVO 5) Same Survival : “early” CT or “wait for symptoms (Rustin et al 2009)

Median (months) Early7.1 Delayed9.2 p=0.15 (Mann-Whitney test) Number of patients Number of months spent with good GHS score Number of patients Number of months spent with good GHS score Overall time with a good Quality of life shorter if CT given early ( Rustin et al 2009)

. The new “cured cancer” Story ? Life style change Secondary prevention The first year is very tough More cancer, heart disease & other chronic illness New Sorts of illnesses

. Cured Cancer 25% unmet needs 6 months After treatment Armes et al 2009 Lots of people survive cancer At least a quarter- unmet needs from Ca & treatment a year later New cancer & treatment related illnesses emerge months, years, or decades later

The year after treatment 79% 1850 patients (breast, prostate, gynae, C/R, NHL) questionnaires at EOT & 6 months later (66 centres ) 25% unmet needs 6 months after treatment Armes et al JCO 2009

Cancer survivors - more chronic illnesses Lifestyle change more important for cancer survivors than others Obesity Dietary fat intake Exercise Smoking

UK Health & Well Being survey ( Eliot et al 2010) NB: These categories are not all mutually exclusive Sample (over 30s) Healthy N= 4, Cancer survivors with or without other chronic conditions 780 Survivors of other chronic conditions but not cancer 1,372 Cancer survivors without other chronic conditions 413 Cancer survivors with other chronic conditions 367

Selected Health and Well-being outcomes Cancer survivors & CCs versus healthy (odds ratios)

New chronic conditions RT & CT related illnesses eg pelvic cancers 17,000 / year pelvic RT ( UK ) gynaecological, urological, colorectal, anal cancers 100,000 living after pelvic RT Bowel, urinary,sexual issues ?

Severe Adverse events : 5 -10% after 10 years; >10% after 20 years Eifel 1995, Nostrant 1995, Denton 2000, Ooi 2000, Andreyev 2005 Stricture Fistula/ Perforation Transfusion dependent bleeding Secondary cancer

Severe Adverse events : 5 -10% after 10 years; >10% after 20 years Eifel 1995, Nostrant 1995, Denton 2000, Ooi 2000, Andreyev 2005 Stricture Fistula/ Perforation Transfusion dependent bleeding Secondary cancer

25-50% Clusters unexplained changes ; patients don’t tell professionals; neither connect them with useful interventions “It’s the little things put together that wear us down” Open Letter to my oncologist Clinical Oncology “My Oncologist asked how I was – how embarrassing to tell him” “”my gp says for a long time he did not know what was going on …I thought I was ……maiking a fuss

bladder symptoms bowel symptoms Symptom Score Time after treatment (months) Worse Better Davidson et al 2008 Months /years after pelvic RT

conference Risk stratification - cancer, individual, Treatment Kaiser triangle

Cancer registry Radiation episode statistics Chemotherapy prescriptions Hospital episode statistics GP research database Patient reported outcomes Using IT intellegently

Getting help after treatment – What do patients think ?

Build one team- words to avoid.. “Primary” “secondary” “Discharge” Perverse incentives

Cancer patients… … use a lot of beds have lots of outpatient appointments …see their GP a lot … have a lot of tests Cancer patients………

Level of need Estimated number of patients involved (will vary according to cancer, individual & treatment ) Level 1 – supported self-care with quick access back into the system if and when needed to improve early detection c75% (<10%) Level 2 – level of requirement requiring regular primary or secondary care input c20% (90%) Level 3 – highly complex patients requiring case management by an assigned key worker (often a CNS) actively managing and “joining up” care for the patient c5% (<1%) Red = where we are now Economic modeling …. More back to work (first year) Reduce “empty” follow up (early ca) Reduce bed days (advanced ca) “

Is cancer a long term condition ? Yes & No ….

“ Some are born great Some become great Some have greatness thrust upon them” Malvolio Twelfth Night W. Shakespeare Some cancers are born chronic - myeloma Some cancers become chronic breast & prostate Some survivors have chronic illness thrust upon them treatment And some are not chronic at all